Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prestige Consumer Healthcare Inc. Common Stock (NY: PBH )

87.00 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33
Open 87.00
Bid (Size) 34.80 (2)
Ask (Size) 139.20 (2)
Prev. Close 87.00
Today's Range 87.00 - 87.00
52wk Range 62.35 - 88.36
Shares Outstanding 50,059,989
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For February 6, 2025
Via Benzinga

Performance

YTD
+11.94%
+11.94%
1 Month
+17.57%
+17.57%
3 Month
+6.42%
+6.42%
6 Month
+33.31%
+33.31%
1 Year
+28.04%
+28.04%

More News

Read More
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For February 8, 2024
Via Benzinga
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
PBH Stock Earnings: Prestige Consumer Misses EPS, Misses Revenue for Q4 2024
Via InvestorPlace
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For March 15, 2024
Via Benzinga
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
Via Talk Markets
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.